1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. CXO Perspective
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. AI-POWERED CLINICAL TRIAL MANAGEMENT MARKET BY TYPE OF AI SOLUTION
5.1. Introduction
5.2. Clinical Trial Planning and Design
5.3. Patient Recruitment and Enrollment
5.4. Data Management and Analysis
5.5. Monitoring And Oversight
5.6. Safety And Pharmacovigilance
6. AI-POWERED CLINICAL TRIAL MANAGEMENT MARKET BY FUNCTION
6.1. Introduction
6.2. Predictive Analytics
6.3. Natural Language Processing (NLP)
6.4. Machine Learning
6.5. Robotic Process Automation (RPA)
6.6. Image And Signal Processing
7. AI-POWERED CLINICAL TRIAL MANAGEMENT MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical Companies
7.3. Contract Research Organizations (Cros)
7.4. Academic And Research Institutions
7.5. Biotechnology Companies
7.6. Medical Device Manufacturers
8. AI-POWERED CLINICAL TRIAL MANAGEMENT MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type of AI Solution
8.2.2. By Function
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Type of AI Solution
8.3.2. By Function
8.3.3. By End-User
8.3.3.1. Brazil
8.3.3.2. Argentina
8.3.3.3. Others
8.4. Europe
8.4.1. By Type of AI Solution
8.4.2. By Function
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Italy
8.4.4.5. Spain
8.4.4.6. Others
8.5. Middle East and Africa
8.5.1. By Type of AI Solution
8.5.2. By Function
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Type of AI Solution
8.6.2. By Function
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Thailand
8.6.4.7. Indonesia
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medidata Solutions (Acquired by Dassault Systèmes)
10.2. Oracle Corporation
10.3. IBM Corporation
10.4. Veeva Systems
10.5. Clinerion
10.6. Saama Technologies
10.7. Bioclinica
10.8. Arisglobal
10.9. Aicure
10.10. Medable